Evidence map›Paper›PMID 33335418›Full record

ArticleInternational journal of general medicine2020

Molecular Characterization and Disease-Related Morbidities of β-Thalassemia Patients from the Northeastern Part of Iraq.

Shaema Amin, Sana Jalal, Kosar Ali, Luqman Rasool, Tara Osman, Omed Ali, Abdalhamid M-Saeed

Open access · goldAbstract read
In one paragraph

Article in International journal of general medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shaema AminHiwa Hematology/Oncology Sulaymaniyah Cancer Center, Sulaymaniyah, Iraq.ORCID 0000-0002-5600-6511
Sana JalalDepartment of Pathology, College of Medicine, University of Sulaymaniyah, Sulaymaniyah, Iraq.ORCID 0000-0002-6025-9802
Kosar AliDepartment of Medicine, College of Medicine, University of Sulaymaniyah, Sulaymaniyah, Iraq.
Luqman RasoolThalassemia and Congenital Blood Disorders Center, Sulaymaniyah, Iraq.ORCID 0000-0001-5115-3937
Tara OsmanThalassemia and Congenital Blood Disorders Center, Sulaymaniyah, Iraq.
Omed AliOtolaryngology Head and Neck Surgery Center, Sulaymaniyah Teaching Hospital, Sulaymaniyah, Iraq.
Abdalhamid M-SaeedThalassemia and Congenital Blood Disorders Center, Sulaymaniyah, Iraq.
University of Sulaimani · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundβ-thalassemia is a significant problem in the northeastern part of Iraq, and has imposed a huge burden on the health authorities.

objectiveTo identify the molecular characterization and morbidity prevalence in transfusion-dependent thalassemia (TDT) and non-transfusion dependent thalassemia (NTDT) phenotypes in northeastern Iraq. PATIENTS AND

methodsThis is a cross-sectional study conducted on 242 β-thalassemia patients from 162 families. Reverse hybridization technique and direct gene sequencing were used to characterize β-thalassemia mutations, and medical records of the patients were reviewed with a well-designed questionnaire.

resultsA total of 22 β-globin mutations arranged in 53 different genotypes were identified: IVS-II-1 (G> A) (35.7%), followed by IVS-I-6 (T> C) (18.0%), and codon 8/9 (+G) (8.5%) were the most frequent. Among disease-related morbidities, bone disease amounted to (66.9%), followed by endocrinopathies (32.2%), hepatobiliary complications (28.9%), and pulmonary hypertension (9.9%), whereas thrombosis, extramedullary hemopoiesis, and leg ulcers were less frequent.

conclusionThe overall complications rate was 78.9%, with a growing probability of complications with advanced age, with evidently higher rates in patients with β

Indexed as

HBB mutationsIraqmorbiditiesnon-transfusion dependent thalassemiarisk factorstransfusion dependent thalassemia

Identifiers

PMID33335418
PMCPMC7737013
OpenAlexW3111617523

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.